Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

Everhart, 1991, Irritable bowel syndrome in office-based practice in the United States, Gastroenterology, 100, 998, 10.1016/0016-5085(91)90275-P Jones, 1992, Irritable bowel syndrome in the general population, BMJ, 304, 87, 10.1136/bmj.304.6819.87 Hahn, 1999, Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom, Digestion, 60, 77, 10.1159/000007593 Patrick, 1998, Quality of life in persons with irritable bowel syndrome: development and validation of a new measure, Dig Dis Sci, 43, 400, 10.1023/A:1018831127942 Whitehead, 1996, Impact of irritable bowel syndrome on quality of life, Dig Dis Sci, 41, 2248, 10.1007/BF02071408 Wells, 1997, Clinical economics review: irritable bowel syndrome, Aliment Pharmacol Ther, 11, 1019, 10.1046/j.1365-2036.1997.00262.x Prior, 1993, Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome, Aliment Pharmacol Ther, 7, 175, 10.1111/j.1365-2036.1993.tb00087.x Delvaux, 1998, Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome, Aliment Pharmacol Ther, 12, 849, 10.1046/j.1365-2036.1998.00375.x Zighelboim, 1995, Visceral perception in irritable bowel syndrome: rectal and gastric responses to distension and serotonin type 3 antagonism, Dig Dis Sci, 40, 819, 10.1007/BF02064986 Maxton, 1996, Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?, Aliment Pharmacol Ther, 10, 595, 10.1046/j.1365-2036.1996.30172000.x Goldberg, 1996, Modification of visceral sensitivity and pain and irritable bowel syndrome by 5-HT3 antagonism (ondansetron), Digestion, 57, 478, 10.1159/000201377 Gore, 1990, Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist, Aliment Pharmacol Ther, 4, 139, 10.1111/j.1365-2036.1990.tb00458.x Bardhan, 2000, A double-blind placebo-controlled study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome, Aliment Pharmacol Ther, 14, 23, 10.1046/j.1365-2036.2000.00684.x Camilleri, 1999, Improvement in pain and bowel function in female irritable bowel syndrome patients with alosetron, a 5-HT3-receptor antagonist, Aliment Pharmacol Ther, 14, 1149, 10.1046/j.1365-2036.1999.00610.x Thompson, 1992, Functional bowel disorders and functional abdominal pain, Gastrointest J, 5, 75 Forster, 1997, Alosetron slows colonic transit in patients with irritable bowel syndrome, Gastroenterology, 112, A732 Harding, 1997, Use of a novel electronic data collection system in multicenter studies of irritable bowel syndrome, Aliment Pharmacol Ther, 11, 1073, 10.1046/j.1365-2036.1997.00256.x Klein, 1988, Controlled treatment trials in the irritable bowel syndrome: a critique, Gastroenterology, 95, 232, 10.1016/0016-5085(88)90319-8 Northcutt, 1999, Urgency as an endpoint in IBS, Gastroenterology, 116, A1036 Mangel, 1998, Adequate relief as an endpoint in clinical trials in irritable bowel syndrome, J Int Med Res, 26, 76, 10.1177/030006059802600203 Mangel, 1999, Validation of adequate relief as an endpoint in irritable bowel syndrome, Gastroenteorlogy, 116, A1035 Miura, 1999, Central modulation of rectal distension-induced blood pressure changes by alosetron, a 5-HT3 receptor antagonist, Dig Dis Sci, 44, 20, 10.1023/A:1026633629141 Drossman, 1997, Irritable bowel syndrome: a technical review for practice guideline development, Gastroenterology, 112, 2120, 10.1053/gast.1997.v112.agast972120 Silverman, 1997, Comparing regional activity associated with visceral stimuli in male and female patients, J Nucl Med, 38, 237P Degen, 1996, Variability of gastrointestinal transit in healthy women and men, Gut, 39, 299, 10.1136/gut.39.2.299 Cook, 1998, Gender differences in bowel function, Digestion, 59, 282 Nguyen, 1995, Evidence of gender differences in esophageal pain threshold, Am J Gastroenterol, 90, 901